Irccs Humanitas Research Hospital

Rozzano 20089

1 studies enrolling now · 5 studies all time

What they study most

Advanced Cholangiocarcinoma, Alpha-fetoprotein (AFP)-Producing Gastric Cancer, Breast Cancer, EGFR Exon 19 Deletion, EGFR L858R, Extragonadal Yolk Sac Tumors, FGFR2 Fusions, Gene Rearrangement, Glypican-3 (GPC3)-Positive Squamous Non-small Cell Lung Cancer, Local Advanced Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma, Multifocal Motor Neuropathy (MMN)

Studies at this site

• A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors — Recruiting now
• Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement — Recruiting now
• A Clinical Trial to Investigate the Long-term Safety and Tolerability, Efficacy, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of ARGX-117 in Adults With Multifocal Motor Neuropathy — Running, not enrolling
• HERTHENA-Lung02: A Study of Patritumab Deruxtecan Versus Platinum-based Chemotherapy in Metastatic or Locally Advanced EGFRm NSCLC After Failure of EGFR TKI Therapy — Running, not enrolling
• Nodal Burden and Nodal Recurrence in Patients With Isolated Tumor Cells After Neoadjuvant Chemotherapy Treated With Axillary Dissection or Nodal Radiation: the OPBC-05/EUBREAST-14R/ICARO Study — Completed